Acute Pain Clinical Trials

Find Acute Pain Clinical Trials Near You

Evaluation of the Effectiveness of Two Methods of Regional Anesthesia During Subcutaneous Implantable Cardioverter-defibrillator (SICD) Implantation Procedure.

Status: Recruiting
Location: See location...
Intervention Type: Procedure, Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Our study consists of a combination of regional blockade ('local' anesthesia) of the anterior and lateral chest wall in the form of a thin needle prick and the supply of local anesthetic drugs to the area of the relevant chest wall structures to exclude all stimuli, including pain from the operative site. A short-acting analgesic and sedative drug will be administered intravenously throughout the procedure - in a dose that allows the required contact between the patient and the anesthetist. If necessary, the dose of the drug may be increased to maintain pain comfort throughout the procedure. The anesthetic team will be with the patient throughout the procedure to ensure comfort and safety.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 90
Healthy Volunteers: f
View:

• patients aged 18-90 years requiring S-ICD implantation for cardiac indications,

• high risk of anesthesia (ASA II or higher), patients giving informed consent to participate in the study.

Locations
Other Locations
Poland
4th Military Clinical Hospital with Polyclinic
RECRUITING
Wroclaw
Contact Information
Primary
Marek Szamborski, MD
mszamborski@4wsk.pl
698448639
Time Frame
Start Date: 2024-06-16
Estimated Completion Date: 2025-12-01
Participants
Target number of participants: 32
Treatments
Active_comparator: Group I (PSP+SSAP)
Group I will include patients undergoing PSP(Pectoserratus plane block)+SSAP(Superficial serratus anterior plane block) (20+40ml) The solution is defined as a combination of 0.125% ropivacaine solution with 0.25% lidocaine solution in a total volume of 60ml of liquid administered.
Active_comparator: Group I (SPIP+SSAP)
Group II will include patients undergoing SPIP(Superficial parastenal intercostal plane block)+SSAP(Superficial serratus anterior plane block) (20+40ml) The solution is defined as a combination of 0.125% ropivacaine solution with 0.25% lidocaine solution in a total volume of 60ml of liquid administered.
Related Therapeutic Areas
Sponsors
Leads: 4th Military Clinical Hospital with Polyclinic, Poland

This content was sourced from clinicaltrials.gov

Similar Clinical Trials